Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3676 AL 3690

Implications for reactive oxygen species in schizophrenia pathogenesis

Koga M, Serritella AV, Sawa A, Sedlak TW.

Schizophr Res. 2016 Sep;176(1):52-71. doi: 10.1016/j.schres.2015.06.022. Epub 2015 Nov 15.

Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort

Toomsoo T, Liepelt-Scarfone I, Kerner R, Kadastik-Eerme L, Asser T, Rubanovits I, Berg D, Taba P.

J Ultrasound Med. 2016 Jan;35(1):17-23. doi: 10.7863/ultra.14.12069. Epub 2015 Nov 20.

Dysphagia in Parkinson's Disease

Suttrup I, Warnecke T.

Dysphagia. 2016 Feb;31(1):24-32. doi: 10.1007/s00455-015-9671-9. Epub 2015 Nov 21.

Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature

Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y.

Neurol Sci. 2016 Mar;37(3):423-30. doi: 10.1007/s10072-015-2414-8. Epub 2015 Nov 21.

Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches

Ricciardi L, Baggio P, Ricciardi D, Morabito B, Pomponi M, Bentivoglio AR, Bernabei R, Maestri R, Frazzitta G, Volpe D.

Neurol Sci. 2016 Mar;37(3):431-6. doi: 10.1007/s10072-015-2421-9. Epub 2015 Nov 21.

Implications of gamma band activity in the pedunculopontine nucleus

Garcia-Rill E, Luster B, D'Onofrio S, Mahaffey S, Bisagno V, Urbano FJ.

J Neural Transm (Vienna). 2016 Jul;123(7):655-665. doi: 10.1007/s00702-015-1485-2. Epub 2015 Nov 23.

Bullous pemphigoid: What's ahead?

Furue M, Kadono T.

J Dermatol. 2016 Mar;43(3):237-40. doi: 10.1111/1346-8138.13207. Epub 2015 Nov 25.

Dementia with Lewy bodies: The emerging role of primary care

Tang EY, Burn D, Taylor JP, Robinson L.

Eur J Gen Pract. 2016;22(1):53-7. doi: 10.3109/13814788.2015.1101061. Epub 2015 Nov 25.

Two-Year Trajectory of Fall Risk in People With Parkinson Disease: A Latent Class Analysis

Paul SS, Thackeray A, Duncan RP, Cavanaugh JT, Ellis TD, Earhart GM, Ford MP, Foreman KB, Dibble LE.

Arch Phys Med Rehabil. 2016 Mar;97(3):372-379.e1. doi: 10.1016/j.apmr.2015.10.105. Epub 2015 Dec 1.

BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson׳s disease

Ledreux A, Boger HA, Hinson VK, Cantwell K, Granholm AC.

Brain Res. 2016 Jan 15;1631:34-45. doi: 10.1016/j.brainres.2015.11.028. Epub 2015 Nov 19.

Manganese neurotoxicity: behavioral disorders associated with dysfunctions in the basal ganglia and neurochemical transmission

Bouabid S, Tinakoua A, Lakhdar-Ghazal N, Benazzouz A.

J Neurochem. 2016 Feb;136(4):677-691. doi: 10.1111/jnc.13442. Epub 2015 Dec 28.

Transcriptome profiling in Parkinson's leukocytes: from early diagnostics to neuroimmune therapeutic prospects

Simchovitz A, Soreq L, Soreq H.

Curr Opin Pharmacol. 2016 Feb;26:102-9. doi: 10.1016/j.coph.2015.10.007. Epub 2015 Nov 21.

Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipids

Kubo SI.

Expert Opin Ther Targets. 2016 Nov;20(11):1301-1310. doi: 10.1517/14728222.2016.1086340. Epub 2015 Sep 7.

Laparoscopic gastrojejunostomy for superior mesenteric artery syndrome in a patient with Parkinson's disease

Chung A, Smith LI, McMurran A, Ali A.

Scott Med J. 2016 Feb;61(1):51-5. doi: 10.1177/0036933015619290. Epub 2015 Nov 26.

An autopsied case of unclassifiable sporadic four-repeat tauopathy presenting with parkinsonism and speech disturbances

Iwasaki Y, Mori K, Ito M, Tatsumi S, Mimuro M, Kuwano R, Hasegawa M, Yoshida M.

Neuropathology. 2016 Jun;36(3):295-304. doi: 10.1111/neup.12274. Epub 2015 Nov 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias